Picture of Rapt Therapeutics logo

RAPT — Rapt Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Rapt Therapeutics Q2 Net Income USD -27.663 Million

Aug 08 (Reuters) - Rapt Therapeutics Q2 operating income USD -29.33 million.
* Q2 basic EPS USD -0.71
* Q2 operating expenses USD 29.33 million

Recent news on Rapt Therapeutics

See all news